Englander Institute for Precision Medicine

Publications

Found 785 results
Author Title Type [ Year(Asc)]
2022
Han Y, Lee T, He Y, Raman R, Irizarry A, M Martin L, Giaccone G.  2022.  The regulation of CD73 in non-small cell lung cancer.. Eur J Cancer. 170:91-102.
Montrose DC, Galluzzi L.  2022.  Restored Ketosis Drives Anticancer Immunity in Colorectal Cancer.. Cancer Res. 82(8):1464-1466.
Ullmann TM, Thiesmeyer JW, Lee YJoo, Beg S, Mosquera JMiguel, Elemento O, Fahey TJ, Scognamiglio T, Houvras Y.  2022.  RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype.. Ann Surg Oncol.
Galassi C, Ruan Y, Sato A, Jiménez-Cortegana C, Klapp V, Bloy N, Guilbaud E, Petroni G, Buqué A, Galluzzi L et al..  2022.  RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells.. Methods Cell Biol. 172:145-161.
Laurent P, Yang C, Rendeiro AF, Nilsson-Payant BE, Carrau L, Chandar V, Bram Y, tenOever BR, Elemento O, Ivashkiv LB et al..  2022.  Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19.. Sci Immunol. 7(75):eadd4906.
Shohdy KS, Villamar DM, Cao Y, Trieu J, Price KS, Nagy R, Tagawa ST, Molina AM, Sternberg CN, Nanus DM et al..  2022.  Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.. Br J Cancer. 126(3):430-439.
Leung W, Teater M, Durmaz C, Meydan C, Chivu AG, Chadburn A, Rice EJ, Muley A, Camarillo JM, Arivalagan J et al..  2022.  SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis.. Cancer Discov. 12(7):1782-1803.
Buyukozkan M, Suhre K, Krumsiek J.  2022.  SGI: automatic clinical subgroup identification in omics datasets.. Bioinformatics. 38(2):573-576.
Kulm S, Kofman L, Mezey J, Elemento O.  2022.  Simple Linear Cancer Risk Prediction Models With Novel Features Outperform Complex Approaches.. JCO Clin Cancer Inform. 6:e2100166.
Paulson TG, Galipeau PC, Oman KM, Sanchez CA, Kuhner MK, Smith LP, Hadi K, Shah M, Arora K, Shelton J et al..  2022.  Somatic whole genome dynamics of precancer in Barrett's esophagus reveals features associated with disease progression.. Nat Commun. 13(1):2300.
Park J, Kim J, Lewy T, Rice CM, Elemento O, Rendeiro AF, Mason CE.  2022.  Spatial omics technologies at multimodal and single cell/subcellular level.. Genome Biol. 23(1):256.
Björndahl L, Barratt CLR, Mortimer D, Agarwal A, Aitken RJ, Alvarez JG, Aneck-Hahn N, Arver S, Baldi E, Bassas L et al..  2022.  Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology.. Hum Reprod. 37(11):2497-2502.
Joshua AM, Armstrong A, Crumbaker M, Scher HI, de Bono J, Tombal B, Hussain M, Sternberg CN, Gillessen S, Carles J et al..  2022.  Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER.. Eur J Cancer. 170:285-295.
Park J, Foox J, Hether T, Danko DC, Warren S, Kim Y, Reeves J, Butler DJ, Mozsary C, Rosiene J et al..  2022.  System-wide transcriptome damage and tissue identity loss in COVID-19 patients.. Cell Rep Med. 3(2):100522.
Petroni G, Buqué A, Coussens LM, Galluzzi L.  2022.  Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment.. Nat Rev Drug Discov. 21(6):440-462.
van der Mijn JC, Chen Q, Laursen KB, Khani F, Wang X, Dorsaint P, Sboner A, Gross SS, Nanus DM, Gudas LJ.  2022.  Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR).. Mol Carcinog. 61(9):851-864.
Ciccarese C, Iacovelli R, Sternberg CN, Gillessen S, Tortora G, Fizazi K.  2022.  Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysis.. Eur J Cancer. 173:276-284.
Alnajar H, Ravichandran H, Rendeiro AFigueiredo, Ohara K, Zoughbi WAl, Manohar J, Greco N, Sigouros M, Fox J, Muth E et al..  2022.  Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab.. Cold Spring Harb Mol Case Stud. 8(3)
Schad SE, Chow A, Mangarin L, Pan H, Zhang J, Ceglia N, Caushi JX, Malandro N, Zappasodi R, Gigoux M et al..  2022.  Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions.. J Exp Med. 219(6)
Yu H, Sfakianos JP, Wang L, Hu Y, Daza J, Galsky MD, Sandhu HS, Elemento O, Faltas BM, Farkas AM et al..  2022.  Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT-Stromal and Tgfβ-Dependent Mechanisms.. Mol Cancer Ther. 21(11):1729-1741.
Lord BD, Martini RN, Davis MB.  2022.  Understanding how genetic ancestry may influence cancer development.. Trends Cancer. 8(4):276-279.
Roberts LR, Rivers BM, Yates CC, Newman LA, Sarkodie BD, Davis MB, Asare-Aboagye Y, Adjei AA, Harris AE, Awuah B.  2022.  Unmet Needs in Oncology Clinical Research and Treatment in Africa: Focus on Ghana.. Oncologist. 27(9):760-767.
Kim J, Rustam S, Mosquera JMiguel, Randell SH, Shaykhiev R, Rendeiro AF, Elemento O.  2022.  Unsupervised discovery of tissue architecture in multiplexed imaging.. Nat Methods. 19(12):1653-1661.
Mordoh A, Aris M, Carri I, Bravo AInés, Podaza E, Pardo JCarlos Tri, Cueto GRubén, Barrio MMarcela, Mordoh J.  2022.  An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases.. Front Immunol. 13:842555.
Batra R, Uni R, Akchurin OM, Alvarez-Mulett S, Gómez-Escobar LG, Patino E, Hoffman KL, Simmons W, Chetnik K, Buyukozkan M et al..  2022.  Urine-based multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS.. medRxiv.